Co-presence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian colorectal cancer samples.
EBV
Syrian population
cancer phenotype
colorectal cancer
high-risk HPV
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 10 2020
02 10 2020
Historique:
pubmed:
19
3
2020
medline:
22
6
2021
entrez:
19
3
2020
Statut:
ppublish
Résumé
We recently performed two studies exploring the presence of Epstein-Barr virus (EBV) and high-risk human papillomaviruses (HPVs) types 16, 18, 31, 33 and 35 in human colorectal cancers from the Syrian population. Herein, we report that EBV and high-risk HPVs are co-present in colorectal cancers from Syria. We reveal that 17 (~17%) of 102 cancer samples are positive for both EBV and high-risk HPVs and their co-presence is associated with high/intermediate grade invasive carcinomas. These data suggest that EBV and high-risk HPVs are co-present in human colorectal cancers where they might cooperate on the initiation and/or progression of these cancers. Thus, we believe that future studies are necessary to confirm the co-presence of these oncoviruses and their cooperative role in human colorectal carcinogenesis.
Identifiants
pubmed: 32186955
doi: 10.1080/21645515.2020.1726680
pmc: PMC7644212
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2403-2407Références
Hum Genomics. 2013 Nov 27;7:23
pubmed: 24279398
Asian Pac J Cancer Prev. 2015;16(17):7883-7
pubmed: 26625815
Transl Oncol. 2018 Jun;11(3):593-598
pubmed: 29547758
Front Oncol. 2018 Jul 02;8:250
pubmed: 30035100
Ai Zheng. 2006 Nov;25(11):1356-60
pubmed: 17094901
Pol J Pathol. 2015 Jun;66(2):154-60
pubmed: 26247529
Med Oncol. 2018 Sep 5;35(11):140
pubmed: 30187207
Cell Adh Migr. 2015;9(5):392-3
pubmed: 26177717
Turk J Med Sci. 2014;44(3):501-3
pubmed: 25558656
Am J Transplant. 2010 Sep;10(9):2043-50
pubmed: 20883538
Colorectal Dis. 2013 Aug;15(8):e420-8
pubmed: 23895733
Asian Pac J Cancer Prev. 2018 Jan 27;19(1):193-198
pubmed: 29373913
Hum Vaccin Immunother. 2015;11(4):951-5
pubmed: 25933186
Oral Dis. 2018 May;24(4):497-508
pubmed: 28190296
Infect Agent Cancer. 2014 Jun 03;9:18
pubmed: 24936208
Front Oncol. 2018 May 01;8:111
pubmed: 29765906
Med Hypotheses. 2009 Aug;73(2):184-6
pubmed: 19361933
Int J Cancer. 2009 May 15;124(10):2501-3
pubmed: 19170205
BMC Public Health. 2015 May 02;15:453
pubmed: 25934423
Rev Bras Epidemiol. 2016 Oct-Dec;19(4):791-802
pubmed: 28146168
Iran Biomed J. 2016 Nov;20(5):302-6
pubmed: 26975327
Int J Colorectal Dis. 2011 Feb;26(2):135-42
pubmed: 20809427
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Hum Vaccin Immunother. 2017 Aug 3;13(8):1839-1843
pubmed: 28594305
Tumour Biol. 2011 Aug;32(4):653-9
pubmed: 21625944
Hum Vaccin Immunother. 2014;10(7):1812-21
pubmed: 25424787
Hum Vaccin Immunother. 2017 Jul 3;13(7):1573-1578
pubmed: 28350509
Mem Inst Oswaldo Cruz. 2016 Dec;111(12):731-736
pubmed: 27812599
Viral Immunol. 2017 Jan/Feb;30(1):20-27
pubmed: 27830995
Front Oncol. 2018 Apr 17;8:113
pubmed: 29719817
J Gen Virol. 2015 Jan;96(Pt 1):206-209
pubmed: 25296558
Hum Vaccin Immunother. 2016 Jul 2;12(7):1936-9
pubmed: 27082145
Virus Res. 2017 Mar 2;231:139-147
pubmed: 27826043
Hum Vaccin Immunother. 2019;15(3):603-610
pubmed: 30380978